CRISPR gene editing shows potential for treating genetic diseases. Explore how it may impact Down syndrome treatment and ...

People with Down syndrome, who were not included in either Eisai or Lilly’s late-stage trials, have higher-than-average rates of CAA, and neurologists are concerned that removing amyloid with a ...

In Canada, "the average lifespan of someone with Down syndrome is about 60 years old," said Dr. Brian Skotko, senior author ...

In the study, researchers found that the brains of people diagnosed with Down syndrome and Alzheimer’s disease (DSAD) had twice as much iron and more signs of oxidative damage in cell membranes ...

People with Down syndrome are likely to develop Alzheimer's disease at a young age, with autopsy studies showing that by age 40 years, the brains of individuals with Down syndrome have amyloid ...

People with Down syndrome also have a very high risk of mid- and late-life neurological disorders, and 50–70% may develop Alzheimer’s disease by the age of 60 years.